Gabapentin binds the α2δ subunit of voltage-gated calcium channels; amitriptyline inhibits norepinephrine/serotonin reuptake. Together they represent complementary peripheral/central pain-modulation mechanisms.
Gabapentin binds the α2δ subunit of voltage-gated calcium channels
Together they represent complementary peripheral/central pain-modulation mechanisms.
Gabapentin and tricyclic antidepressants are both established neuropathic-pain options. Comparative and pathway-sequencing trials support the clinical logic of combining mechanistically different agents when monotherapy is inadequate.
Safety information
Dizziness, somnolence, dry mouth, constipation and cognitive effects may occur.
Gabapentin exposure is affected by renal function.
Avoid abrupt discontinuation and review additive CNS depressant burden.
Review the current approved prescribing information, contraindications, interactions, organ-function considerations, pregnancy/lactation advice and patient-specific risks before prescribing.
Evidence context
Gabapentin and tricyclic antidepressants are both established neuropathic-pain options. Comparative and pathway-sequencing trials support the clinical logic of combining mechanistically different agents when monotherapy is inadequate.
The available trials do not prove that this exact fixed-dose Gabalex-AT formulation is superior to titrated separate agents.